[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Invesco Water Resources ETF (PHO)

Invesco Water Resources ETF (PHO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Invesco
  • Assets Under Management 1,969,756,800
  • Shares Outstanding, K 30,360
  • 60-Month Beta 1.00
  • Price/Earnings ttm 22.34
  • Annual Dividend & Yield 0.39 (0.60%)
  • Most Recent Dividend 0.105 on 03/23/26
  • Management Fee 0.59%
  • INDUSTRY GROUPING:

    ETFs - Natural Resources

Options Overview Details

View History
  • Implied Volatility 19.85% (-1.92%)
  • Historical Volatility 15.82%
  • IV Percentile 67%
  • IV Rank 11.04%
  • IV High 113.16% on 11/28/25
  • IV Low 8.27% on 09/09/25
  • Expected Move (DTE 30) 1.33 (2.04%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 16
  • Volume Avg (30-Day) 20
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 940
  • Open Int (30-Day) 853
  • Expected Range 63.55 to 66.21

Price Performance

See More
Period Period Low Period High Performance
1-Month
64.34 +0.84%
on 05/15/26
70.77 -8.32%
on 04/21/26
-4.62 (-6.65%)
since 04/17/26
3-Month
64.34 +0.84%
on 05/15/26
73.56 -11.80%
on 02/26/26
-7.87 (-10.82%)
since 02/18/26
52-Week
64.34 +0.84%
on 05/15/26
74.93 -13.41%
on 10/24/25
-4.38 (-6.32%)
since 05/16/25

Most Recent Stories

More News
AUA 2026: new studies demonstrated Blue Light Cystoscopy benefits in high-risk NMIBC management and cost comparison study

OSLO, Norway , May 18, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the presentation of two Photocure-supported abstracts at the American Urological Association...

PHO : 64.88 (+0.78%)
Photocure ASA: Results for the first quarter of 2026

OSLO, Norway , May 7, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ® revenues of NOK 139.0 million in the first quarter of 2026 (Q1 2025: NOK...

PHO : 64.88 (+0.78%)
New health economic methodology published: comparing cost-effectiveness of BLC versus NBI imaging technology in bladder cancer

OSLO, Norway , May 4, 2026 /PRNewswire/ --  Photocure ASA (OSE: PHO) , the Bladder Cancer Company, announces the publication in 'The Journal of Medical Economics' of a novel health economics...

PHO : 64.88 (+0.78%)
Photocure ASA: Update on Regulatory Classification for OAY Equipment

OSLO, Norway , April 13, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO) today announced that the U.S. Food and Drug Administration (FDA) has communicated to Photocure that it plans to issue...

PHO : 64.88 (+0.78%)
Photocure: Trials in Progress presented at the European Association of Urology (EAU) 2026 congress aim to enable a more personalized bladder cancer care pathway

OSLO, Norway , March 16, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces two "trial in progress" presentations at the 2026 European Association of Urology congress...

PHO : 64.88 (+0.78%)
Asieris: CEVIRA Approved in China as First-in-Class Non-Invasive Therapy for Cervical Precancerous Lesions

OSLO, Norway , March 3, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) communicated today...

PHO : 64.88 (+0.78%)
Photocure ASA: Results for the fourth quarter of 2025

OSLO, Norway , Feb. 18, 2026 /PRNewswire/ --  Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ®  revenues of NOK 135.1 million in the fourth quarter of 2025 (Q4 2024:...

PHO : 64.88 (+0.78%)
The AI Pick-and-Shovel Trade Hiding in Plain Sight: Stocks & ETFs to Invest in Water

As Microsoft unveils a new community-friendly face on its data center land grab, our top technical strategist explains the ‘Mad Max’-style investing thesis bubbling up under the surface.

MSFT : 423.54 (+0.38%)
CGW : 62.18 (+0.99%)
AQWA : 18.50 (+0.08%)
FIW : 101.00 (+0.83%)
PHO : 64.88 (+0.78%)
UUUU : 17.40 (-5.49%)
GEV : 1,012.25 (-3.52%)
VLTO : 86.71 (+2.22%)
XYL : 108.30 (+0.17%)
LEU : 172.95 (-5.28%)
ECL : 249.21 (+0.64%)
The impact of avoiding recurrence: New BRAVO Study abstract at SUO 2025 demonstrates Cost Neutrality in Blue Light versus White Light Cystoscopy comparison

OSLO, Norway , Dec. 8, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the presentation of a health economics abstract from the BRAVO study at the Society...

PHO : 64.88 (+0.78%)
Photocure ASA: Results for the third quarter of 2025

OSLO, Norway , Oct. 29, 2025 /PRNewswire/ --  Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ® revenues of NOK 134.1 million in the third quarter of 2025 (Q3 2024:...

PHO : 64.88 (+0.78%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 30%. The market has bounced from oversold territory. Beware of a potential mean reversion.

See More Share

Fund Summary

The Invesco Water Resources ETF is based on the NASDAQ OMX US Water Index. The Fund generally will invest at least 90% of its total assets in common stocks and American depositary receipts (ADRs) of companies in the water industry that comprise the Underlying Index. The Underlying Index seeks to track...

See More

Key Turning Points

3rd Resistance Point 65.99
2nd Resistance Point 65.61
1st Resistance Point 65.25
Last Price 64.88
1st Support Level 64.51
2nd Support Level 64.13
3rd Support Level 63.77

See More

52-Week High 74.93
Fibonacci 61.8% 70.88
Fibonacci 50% 69.63
Fibonacci 38.2% 68.39
Last Price 64.88
52-Week Low 64.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.